DK0798002T3 - Anti-blodpladeafledtvækstfaktor-antistoffer til behandling af restenose - Google Patents

Anti-blodpladeafledtvækstfaktor-antistoffer til behandling af restenose

Info

Publication number
DK0798002T3
DK0798002T3 DK97106298T DK97106298T DK0798002T3 DK 0798002 T3 DK0798002 T3 DK 0798002T3 DK 97106298 T DK97106298 T DK 97106298T DK 97106298 T DK97106298 T DK 97106298T DK 0798002 T3 DK0798002 T3 DK 0798002T3
Authority
DK
Denmark
Prior art keywords
growth factor
restenosis
treatment
derived growth
platelet derived
Prior art date
Application number
DK97106298T
Other languages
English (en)
Inventor
Russell Ross
Michael A Reidy
Elaine W Raines
Volkhard Lindner
Gordon A A Ferns
Christopher Jackson
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of DK0798002T3 publication Critical patent/DK0798002T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK97106298T 1991-01-17 1992-01-17 Anti-blodpladeafledtvækstfaktor-antistoffer til behandling af restenose DK0798002T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64175891A 1991-01-17 1991-01-17

Publications (1)

Publication Number Publication Date
DK0798002T3 true DK0798002T3 (da) 2002-08-19

Family

ID=24573729

Family Applications (2)

Application Number Title Priority Date Filing Date
DK92905617.4T DK0573510T3 (da) 1991-01-17 1992-01-17 Antivækstfaktor antistoffer i behandlingen af vaskulær stenose
DK97106298T DK0798002T3 (da) 1991-01-17 1992-01-17 Anti-blodpladeafledtvækstfaktor-antistoffer til behandling af restenose

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK92905617.4T DK0573510T3 (da) 1991-01-17 1992-01-17 Antivækstfaktor antistoffer i behandlingen af vaskulær stenose

Country Status (10)

Country Link
US (1) US5648076A (da)
EP (2) EP0798002B1 (da)
JP (2) JP3667752B2 (da)
AT (2) ATE164521T1 (da)
AU (1) AU665529B2 (da)
CA (1) CA2100876A1 (da)
DE (2) DE69224983T2 (da)
DK (2) DK0573510T3 (da)
ES (2) ES2117046T3 (da)
WO (1) WO1992012734A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770198A (en) * 1988-05-18 1998-06-23 The Research Foundation Of The State Of New York Platelet-specific chimeric 7E3 immunoglobulin
CN1186439A (zh) * 1995-06-07 1998-07-01 森特克公司 血小板特异性的嵌合性免疫球蛋白及其使用方法
US7241568B2 (en) 1996-04-03 2007-07-10 Kyowa Hakko Kogyo Co., Ltd. Anti-fibroblast growth factor-8 monoclonal antibody
WO1998035697A1 (en) * 1997-02-14 1998-08-20 Roche Diagnostics Gmbh Improved method for the reduction of neointima formation after angioplasty
DE60226253T2 (de) * 2001-06-28 2009-05-14 Kyowa Hakko Kogyo Co., Ltd. Humanisierter antikörper gegen fibroblastenwachstumsfaktor 8 und fragment des antikörpers
EP1680140B1 (en) * 2003-10-16 2011-04-20 Imclone LLC Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof
US9339593B2 (en) * 2007-01-11 2016-05-17 Robert L. Bjork, JR. Drug-eluting coronary artery stent coated with anti-platelet-derived growth factor antibodies overlaying extracellular matrix proteins with an outer coating of anti-inflammatory (calcineurin inhibitor) and/or anti-proliferatives
JP5602432B2 (ja) * 2007-01-11 2014-10-08 ロバート ラマール ジュニア ビョーク 経皮的冠動脈インターベンション用の多剤溶出冠動脈ステント
WO2016149103A1 (en) * 2015-03-13 2016-09-22 The Regents Of The University Of California Monoclonal antibody for prevention and/or treatment of astrovirus disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3852561T2 (de) * 1987-03-03 1995-07-13 Takeda Chemical Industries Ltd Monoklonaler Antikörper, Hybridomen, ihre Herstellung und ihre Verwendung.
CA1339356C (en) * 1988-02-02 1997-08-26 Lewis T. Williams Human platelet-derived growth factor receptor
US5268358A (en) * 1988-12-08 1993-12-07 Cor Therapeutics, Inc. PDGF receptor blocking peptides
AU6605690A (en) * 1989-10-27 1991-05-31 Du Pont Merck Pharmaceutical Company, The Monoclonal antibodies to basic fibroblast growth factor that inhibit its biological activity
JP4350370B2 (ja) * 2002-12-27 2009-10-21 株式会社半導体エネルギー研究所 電子回路及び電子機器

Also Published As

Publication number Publication date
JP2002316945A (ja) 2002-10-31
JPH06504551A (ja) 1994-05-26
AU1327492A (en) 1992-08-27
ATE164521T1 (de) 1998-04-15
EP0798002B1 (en) 2002-04-24
EP0798002A1 (en) 1997-10-01
CA2100876A1 (en) 1992-07-18
DE69224983T2 (de) 1998-07-30
ES2174144T3 (es) 2002-11-01
JP3667752B2 (ja) 2005-07-06
EP0573510B1 (en) 1998-04-01
US5648076A (en) 1997-07-15
WO1992012734A1 (en) 1992-08-06
ATE216592T1 (de) 2002-05-15
ES2117046T3 (es) 1998-08-01
DK0573510T3 (da) 1998-04-27
EP0573510A1 (en) 1993-12-15
AU665529B2 (en) 1996-01-11
DE69224983D1 (de) 1998-05-07
DE69232579T2 (de) 2002-08-22
DE69232579D1 (de) 2002-05-29

Similar Documents

Publication Publication Date Title
DE69220355D1 (de) Selbstausspreizbare, vaskuläre Endoprothese
DE4396657T1 (de) Gefäßprothese
AU629388B2 (en) An expandable transluminal atherectomy catheter system and method for the treatment of arterial stenoses
FI924814A (fi) Medicinska aotergivningsanordning foer roentgenbild med automatisk exponeringsfunktion
DK189886A (da) Roerformet proteseartikel
DE69419877D1 (de) Ortsfeste Gefässprothese
DE69419804T2 (de) Ortsfeste Gefässprothese
DE69122369T2 (de) Dreilagige Gefässprothese
DE69229539T2 (de) Okklusionsvorrichtung zur Reparatur von Herz- und Gefäss-Defekten
DE69632390D1 (de) Implantierbare vaskuläre und endoluminale Stents
DE68911941D1 (de) Gefässprothese.
DK0798002T3 (da) Anti-blodpladeafledtvækstfaktor-antistoffer til behandling af restenose
SE8803472A (da)
DE69104180D1 (de) Prothetische kniescheibekomponente.
AU6178094A (en) Polyurethane-coated intravascular prostheses (stents) for the treatment of blood vessel stenosis
DK452089D0 (da) Anvendelse af ace-inhibitorer
FR2662933B1 (fr) Dispositif de mise en place des protheses.
DK0661981T3 (da) Anvendelse af hyaluronsyre og derivater heraf til forebyggelse mod arteriel restenose
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
NO932346D0 (no) Sluttstykke for ammunisjons-utkastingsroer med tilhoerende utkastingsroer
DE29705218U1 (de) Teilmantel-Gefäßstütze zur medizinischen Behandlung von verengten Gefäßen, insbesondere Gefäßarealen mit Gefäßabzweig
ES1023771Y (es) Protesis vascular tubular perfeccionada.
DE9310335U1 (de) Carbon-Gefäßprothesen
IT8867135A0 (it) Protesi ad espansione endoluminale particolarmente per il trattamentodi patologie vascolari
ITTO910182A0 (it) Trattamento urologico maschile